GOSY yields 2000000.00% · ABBV yields 3.09%● Live data
📍 GOSY pulled ahead of the other in Year 1
Combined, GOSY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GOSY + ABBV for your $10,000?
GeckoSystems International Corporation engages in the development and supply of mobile robot solutions for safety, security, and service to the consumer, business, and government markets. It offers mobile service robots (MSRs) that automatically self-navigate homes or workplace. The company's products comprise GeckoNav, an automatic navigation control system based on fuzzy hybrid architecture; GeckoSuper that acts as the central hub through which GeckoSavants communicate with each other; GeckoScheduler that enables mobile robots to timely and repetitively remind the care receiver of various events; GeckoChat, a conversational artificial intelligence system that allows the user to verbally interact with those GSI systems, which have GeckoChat bilateral communication capability; and GeckoTrak, which merges and interprets data from sensor systems to achieve sensor fusion to automatically follow a designated person anywhere in the home. Its products also include GeckoSPIO, a robot controller circuit board that contains passive and active components; GeckoImager, which allows the system to process approximately 2,000 times more raw data than the CompoundedSensorArray system; GeckoOrient, which merges sensor data from odometry for enhanced orientation accuracy while errand running, patrolling, or following a designated person; GeckoSteer, a solution to address issues unique to the collision proof wheelchair; and GeckoMotorController that uses feedback from optical encoders to control wheel velocity. In addition, the company provides GeckoZap, a test, calibrate, and debug software suite; and CareBot MSR technology. GeckoSystems Intl. Corp. was founded in 1997 and is based in Conyers, Georgia.
Full GOSY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.